Living with a mental health condition like schizophrenia can be incredibly isolating. At the same time, many people also struggle with long-term lung issues. New research suggests these two very different conditions might actually share some of the same underlying genetic roots.
By looking at data from over 320,000 people across different ancestries, researchers identified 16 new genetic variants linked to schizophrenia. They also found that specific genes, like WBP1L and CNNM2, appear in both the mental health and lung disease profiles. This means the two conditions might share a common biological foundation.
While these findings are early, they offer a path forward for doctors. Because these conditions share genetic traits, it may eventually be possible to use the same medications to treat both symptoms. However, these results are based on gene models rather than clinical trials, so more research is needed before new treatments can be used in clinics.
Common questions
What did the study find about schizophrenia?
The analysis identified 16 previously unreported genetic variants associated with schizophrenia across different ancestries. These findings help researchers better understand the biological roots of the condition and identify specific genes, such as WBP1L and CNNM2, that play a role in its biology.
How is this related to lung disease?
The study found that schizophrenia and chronic pulmonary diseases share a similar inheritance architecture. This means they share common genetic links. These findings suggest that the two conditions may have overlapping biological traits that could eventually help doctors predict risks for both.
Could this lead to new treatments?
The discovery of shared genes like WBP1L and CNNM2 points toward potential drug repurposing. This means a medication used for one condition might eventually be used for the other. However, these are currently potential opportunities based on gene models, not results from clinical trials.
